The manufacturer of the SDB recommends a cut-off of 4.0 U/g Hb to define deficiency and 6.0 U/g Hb to define the upper bound of intermediate activity [47]. The gene discussed is GSTM1; the disease is hyperinsulinemic hypoglycemia, familial, 4.